APP下载

特利加压素治疗80例脓毒血症难治性休克的分析

2017-10-10王书豹

上海医药 2017年17期

王书豹

摘 要 目的:探讨特利加压素治疗脓毒血症难治性休克的应用价值。方法:选择80例脓毒血症难治性休克患者,经多巴胺和去甲肾上腺素治疗无效后给予特利加压素治疗,观察记录给予特利加压素6 h、12 h、24 h患者的心率、血压、休克指数和尿量的变化。结果:特利加压素使用后6 h患者的平均动脉压(MAP)明显升高,休克指数显著降低(P<0.05);特利加压素使用后12 h、24 h患者的MAP和尿量明显升高,休克指数和心率显著降低(P<0.05)。结论:脓毒血症难治性休克患者应用特利加压素的临床效果显著。

关键词 特利加压素 脓毒血症 难治性休克

中图分类号:R631.4 文献标识码:B 文章编号:1006-1533(2017)17-0023-02

Clinical efficacy of terlipressin in the treatment of 80 cases of intractable septic shock

WANG Shubao*(Department of Critical Care Medicine, General Hospital of China Pingmei Shenma Group, Henan Pingdingshan 467000, China)

ABSTRACT Objective: To investigate the value of the application of terlipressin in the treatment of intractable septic shock. Methods: Eighty cases of patients with refractory septic shock were selected and treated with terlipressin after dopamine and norepinephrine were invalid. The changes of heart rate and blood pressure, urine volume and shock index were observed and recorded at 6 h, 12 h and 24 h after terlipressin was used. Results: The mean arterial pressure (MAP) was significantly risen while shock index was significantly decreased at 6 h after treatment (P<0.05). The MAP and urine volume were obviously risen while shock index and heart rate were decreased at 12 h and 24 h after treatment (P<0.05). Conclusion: The clinical effect of terlipressin for the treatment of intractable septic shock in patients is significant.

KEy WORDS terlipressin; sepsis; refractory shock

休克是在外科手术、缺氧和再灌注损伤、严重烧伤或创伤、严重感染时常见并发症之一,虽然近些年来国内外抗感染治疗及器官功能支持方面获得了较大的突破,但对多巴胺、去甲肾上腺素无反应的脓毒血症难治性休克死亡率仍然很高[1-2]。现有临床实践经验表明,特利加压素用于治疗脓毒血症难治性休克的效果较好[3],本文对此进行研究报道如下。

1 资料与方法

1.1 一般资料

选择2015年至2016年的80例脓毒血症难治性休克患者为观察对象,均符合国际脓毒血症会议(International Sepsis Conference)推荐的脓毒血症难治性休克诊断标准[4],器官功能不全采用MODS评分[5],均在5分以上(含5分)。其中,男性53例,女性27例,患者年龄21~73岁,平均年龄为(42.53±2.25)岁;原发疾病:重症胰腺炎24例,肠穿孔20例,急性化脓性胆管炎17例,重症肺炎15例(其中伴急性呼吸窘迫综合征6例),严重颅脑外伤合并急性呼吸窘迫综合征4例。

1.2 治疗方法

遵循中华医学会重症医学分会的“中国严重脓毒症/脓毒性休克治疗指南”[6],若平均动脉压(mean arterial pressure, MAP)在60 mmHg以下,先给予盐酸多巴胺注射液(生产企业:远大药业有限公司;……

登录APP查看全文